• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主预激发的埃博拉病毒糖蛋白暴露出一个疏水性NPC1受体结合口袋,揭示了一种广泛中和抗体的靶点。

Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.

作者信息

Bornholdt Zachary A, Ndungo Esther, Fusco Marnie L, Bale Shridhar, Flyak Andrew I, Crowe James E, Chandran Kartik, Saphire Erica Ollmann

机构信息

Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.

出版信息

mBio. 2016 Feb 23;7(1):e02154-15. doi: 10.1128/mBio.02154-15.

DOI:10.1128/mBio.02154-15
PMID:26908579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4791852/
Abstract

UNLABELLED

The filovirus surface glycoprotein (GP) mediates viral entry into host cells. Following viral internalization into endosomes, GP is cleaved by host cysteine proteases to expose a receptor-binding site (RBS) that is otherwise hidden from immune surveillance. Here, we present the crystal structure of proteolytically cleaved Ebola virus GP to a resolution of 3.3 Å. We use this structure in conjunction with functional analysis of a large panel of pseudotyped viruses bearing mutant GP proteins to map the Ebola virus GP endosomal RBS at molecular resolution. Our studies indicate that binding of GP to its endosomal receptor Niemann-Pick C1 occurs in two distinct stages: the initial electrostatic interactions are followed by specific interactions with a hydrophobic trough that is exposed on the endosomally cleaved GP1 subunit. Finally, we demonstrate that monoclonal antibodies targeting the filovirus RBS neutralize all known filovirus GPs, making this conserved pocket a promising target for the development of panfilovirus therapeutics.

IMPORTANCE

Ebola virus uses its glycoprotein (GP) to enter new host cells. During entry, GP must be cleaved by human enzymes in order for receptor binding to occur. Here, we provide the crystal structure of the cleaved form of Ebola virus GP. We demonstrate that cleavage exposes a site at the top of GP and that this site binds the critical domain C of the receptor, termed Niemann-Pick C1 (NPC1). We perform mutagenesis to find parts of the site essential for binding NPC1 and map distinct roles for an upper, charged crest and lower, hydrophobic trough in cleaved GP. We find that this 3-dimensional site is conserved across the filovirus family and that antibody directed against this site is able to bind cleaved GP from every filovirus tested and neutralize viruses bearing those GPs.

摘要

未标记

丝状病毒表面糖蛋白(GP)介导病毒进入宿主细胞。病毒内化进入内体后,GP被宿主半胱氨酸蛋白酶切割,暴露出一个受体结合位点(RBS),否则该位点会免受免疫监视。在此,我们展示了经蛋白水解切割的埃博拉病毒GP的晶体结构,分辨率为3.3埃。我们将此结构与大量携带突变GP蛋白的假型病毒的功能分析相结合,以分子分辨率绘制埃博拉病毒GP内体RBS图谱。我们的研究表明,GP与其内体受体尼曼-匹克C1(Niemann-Pick C1)的结合分两个不同阶段进行:最初的静电相互作用之后是与内体切割的GP1亚基上暴露的疏水凹槽的特异性相互作用。最后,我们证明靶向丝状病毒RBS的单克隆抗体可中和所有已知的丝状病毒GP,使这个保守的口袋成为开发泛丝状病毒疗法的有希望的靶点。

重要性

埃博拉病毒利用其糖蛋白(GP)进入新的宿主细胞。在进入过程中,GP必须被人类酶切割才能发生受体结合。在此,我们提供了埃博拉病毒GP切割形式的晶体结构。我们证明切割暴露了GP顶部的一个位点,该位点结合受体的关键结构域C,即尼曼-匹克C1(NPC1)。我们进行诱变以找到结合NPC1所必需的位点部分,并绘制切割后的GP中上部带电荷的嵴和下部疏水凹槽的不同作用。我们发现这个三维位点在丝状病毒家族中是保守的,针对该位点的抗体能够结合所测试的每种丝状病毒切割后的GP,并中和携带这些GP的病毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/4791852/8ed61c72bf02/mbo0011626960004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/4791852/6e80e2115818/mbo0011626960001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/4791852/03c6e3d7f26b/mbo0011626960002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/4791852/9129a0c9113b/mbo0011626960003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/4791852/8ed61c72bf02/mbo0011626960004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/4791852/6e80e2115818/mbo0011626960001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/4791852/03c6e3d7f26b/mbo0011626960002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/4791852/9129a0c9113b/mbo0011626960003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e162/4791852/8ed61c72bf02/mbo0011626960004.jpg

相似文献

1
Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.宿主预激发的埃博拉病毒糖蛋白暴露出一个疏水性NPC1受体结合口袋,揭示了一种广泛中和抗体的靶点。
mBio. 2016 Feb 23;7(1):e02154-15. doi: 10.1128/mBio.02154-15.
2
Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by Proximity Ligation.通过邻近连接直接观察埃博拉病毒受体相互作用
mBio. 2021 Jan 12;12(1):e03100-20. doi: 10.1128/mBio.03100-20.
3
Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1.与内体受体尼曼-匹克C1结合的埃博拉病毒糖蛋白
Cell. 2016 Jan 14;164(1-2):258-268. doi: 10.1016/j.cell.2015.12.044.
4
The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.埃博拉病毒糖蛋白的 tetherin 拮抗作用需要完整的受体结合结构域,并且可被 GP1 特异性抗体阻断。
J Virol. 2016 Nov 28;90(24):11075-11086. doi: 10.1128/JVI.01563-16. Print 2016 Dec 15.
5
Ebola virus entry requires the host-programmed recognition of an intracellular receptor.埃博拉病毒进入宿主需要宿主程序化识别细胞内受体。
EMBO J. 2012 Apr 18;31(8):1947-60. doi: 10.1038/emboj.2012.53. Epub 2012 Mar 6.
6
A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.基于病毒粒子的糖蛋白热稳定性分析揭示了丝状病毒进入及其抑制的关键决定因素。
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.00336-20.
7
Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway.埃博拉病毒在胞吞途径中引发融合的直接可视化
mBio. 2016 Feb 9;7(1):e01857-15. doi: 10.1128/mBio.01857-15.
8
A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.埃博拉病毒包膜糖蛋白中的突变以宿主种属和细胞类型特异性的方式限制病毒进入。
J Virol. 2013 Mar;87(6):3324-34. doi: 10.1128/JVI.01598-12. Epub 2013 Jan 9.
9
Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity.两种不同的溶酶体靶向策略赋予具有泛丝状病毒活性的特洛伊木马抗体。
Front Immunol. 2021 Oct 14;12:729851. doi: 10.3389/fimmu.2021.729851. eCollection 2021.
10
Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.埃博拉病毒糖蛋白1(GP1)上N-连接聚糖的综合功能分析
mBio. 2014 Jan 28;5(1):e00862-13. doi: 10.1128/mBio.00862-13.

引用本文的文献

1
agglutinin enhances entry through interactions at specific -linked glycosylation sites on the virus glycoprotein complex.凝集素通过与病毒糖蛋白复合物上特定连接的糖基化位点相互作用来增强病毒进入。
J Gen Virol. 2025 Jun;106(6). doi: 10.1099/jgv.0.002120.
2
Molecular basis for the increased fusion activity of the Ebola virus glycoprotein epidemic variant A82V: Insights from simulations and experiments.埃博拉病毒糖蛋白流行变体A82V融合活性增强的分子基础:来自模拟和实验的见解
Cell Rep. 2025 Apr 22;44(4):115521. doi: 10.1016/j.celrep.2025.115521. Epub 2025 Apr 4.
3
Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies.

本文引用的文献

1
Ebolavirus Evolution: Past and Present.埃博拉病毒的进化:过去与现在
PLoS Pathog. 2015 Nov 12;11(11):e1005221. doi: 10.1371/journal.ppat.1005221. eCollection 2015.
2
Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa.2014-2015 年西非埃博拉病毒疫情的时空分析。
Nature. 2015 Aug 6;524(7563):97-101. doi: 10.1038/nature14594. Epub 2015 Jun 17.
3
Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo.尼曼-皮克病C1蛋白对于埃博拉病毒在体内的复制和致病机制至关重要。
埃博拉病毒病的治疗:从血清疗法到单克隆抗体的应用。
Antibodies (Basel). 2025 Mar 5;14(1):22. doi: 10.3390/antib14010022.
4
Cathepsins in cellular entry of human pathogenic viruses.组织蛋白酶在人类致病病毒的细胞进入过程中的作用
J Virol. 2025 Apr 15;99(4):e0164224. doi: 10.1128/jvi.01642-24. Epub 2025 Mar 26.
5
Identification of Filovirus Entry Inhibitors from Marine Fungus-Derived Indole Alkaloids.从海洋真菌衍生的吲哚生物碱中鉴定丝状病毒进入抑制剂。
Mar Drugs. 2025 Jan 3;23(1):23. doi: 10.3390/md23010023.
6
Decoding the blueprint of receptor binding by filoviruses through large-scale binding assays and machine learning.通过大规模结合试验和机器学习解析丝状病毒受体结合的蓝图。
Cell Host Microbe. 2025 Feb 12;33(2):294-313.e11. doi: 10.1016/j.chom.2024.12.016. Epub 2025 Jan 15.
7
Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38.克里米亚-刚果出血热幸存者产生靶向糖蛋白 GP38 上 11 个重叠区域的保护性非中和抗体。
Cell Rep. 2024 Jul 23;43(7):114502. doi: 10.1016/j.celrep.2024.114502. Epub 2024 Jul 13.
8
Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38.克里米亚-刚果出血热幸存者产生针对病毒糖蛋白GP38上11个重叠区域的保护性非中和抗体。
bioRxiv. 2024 Mar 6:2024.03.02.583110. doi: 10.1101/2024.03.02.583110.
9
Production and Purification of Filovirus Glycoproteins.Filovirus 糖蛋白的生产与纯化。
Methods Mol Biol. 2024;2762:17-25. doi: 10.1007/978-1-0716-3666-4_2.
10
An overview of the role of Niemann-pick C1 (NPC1) in viral infections and inhibition of viral infections through NPC1 inhibitor.Niemann-pick C1(NPC1)在病毒感染中的作用概述,以及通过 NPC1 抑制剂抑制病毒感染。
Cell Commun Signal. 2023 Dec 14;21(1):352. doi: 10.1186/s12964-023-01376-x.
mBio. 2015 May 26;6(3):e00565-15. doi: 10.1128/mBio.00565-15.
4
A comprehensive database of the geographic spread of past human Ebola outbreaks.一个全面的过去人类埃博拉疫情地理传播数据库。
Sci Data. 2014 Oct 23;1:140042. doi: 10.1038/sdata.2014.42. eCollection 2014.
5
Structural basis for Marburg virus neutralization by a cross-reactive human antibody.一种交叉反应性人类抗体对马尔堡病毒中和作用的结构基础
Cell. 2015 Feb 26;160(5):904-912. doi: 10.1016/j.cell.2015.01.041.
6
Mechanism of human antibody-mediated neutralization of Marburg virus.人类抗体介导的马尔堡病毒中和作用机制。
Cell. 2015 Feb 26;160(5):893-903. doi: 10.1016/j.cell.2015.01.031.
7
Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.埃博拉病毒和严重急性呼吸综合征冠状病毒表现出晚期细胞进入动力学:转运至NPC1+内溶酶体是限速步骤的证据。
J Virol. 2015 Mar;89(5):2931-43. doi: 10.1128/JVI.03398-14. Epub 2014 Dec 31.
8
Structures of protective antibodies reveal sites of vulnerability on Ebola virus.保护性抗体的结构揭示了埃博拉病毒上的脆弱位点。
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17182-7. doi: 10.1073/pnas.1414164111. Epub 2014 Nov 17.
9
Ebola virus disease in the Democratic Republic of Congo.刚果民主共和国的埃博拉病毒病。
N Engl J Med. 2014 Nov 27;371(22):2083-91. doi: 10.1056/NEJMoa1411099. Epub 2014 Oct 15.
10
Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.一种新型欧洲丝状病毒进入细胞需要宿主内体半胱氨酸蛋白酶和尼曼-匹克C1蛋白。
Virology. 2014 Nov;468-470:637-646. doi: 10.1016/j.virol.2014.08.019. Epub 2014 Oct 11.